BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou C, Wang S, Zhou Q, Zhao J, Xia X, Chen W, Zheng Y, Xue M, Yang F, Fu D, Yin Y, Atyah M, Qin L, Zhao Y, Bruns C, Jia H, Ren N, Dong Q. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma. Front Oncol 2019;9:1160. [PMID: 31781487 DOI: 10.3389/fonc.2019.01160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan L, Tu Y, Wang K, Han B, Peng H, He C. Exploring protective effect of Glycine tabacina aqueous extract against nephrotic syndrome by network pharmacology and experimental verification. Chin Med 2020;15:79. [PMID: 32765640 DOI: 10.1186/s13020-020-00361-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen B, Zhang Q, Wang X, Wang Y, Cui J, Zhuang H, Tang J. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Aging (Albany NY) 2020;12:3647-61. [PMID: 32090981 DOI: 10.18632/aging.102835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Mu Y, Song F, Yuan K, Zhang Z, Lu Y, Fu R, Zhou D. A Comprehensive Risk Assessment and Stratification Model of Papillary Thyroid Carcinoma Based on the Autophagy-Related LncRNAs. Front Oncol 2021;11:771556. [PMID: 35284335 DOI: 10.3389/fonc.2021.771556] [Reference Citation Analysis]
4 Lei Y, Tang R, Xu J, Zhang B, Liu J, Liang C, Meng Q, Hua J, Yu X, Wang W, Shi S. Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features. Bioengineered 2021;12:3593-602. [PMID: 34238114 DOI: 10.1080/21655979.2021.1951527] [Reference Citation Analysis]
5 Dorn A, Glaß M, Neu CT, Heydel B, Hüttelmaier S, Gutschner T, Haemmerle M. LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. Cancers (Basel) 2020;12:E1227. [PMID: 32414223 DOI: 10.3390/cancers12051227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
6 Glaß M, Dorn A, Hüttelmaier S, Haemmerle M, Gutschner T. Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. Cancers (Basel) 2020;12:E2077. [PMID: 32727085 DOI: 10.3390/cancers12082077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tang X, Zhang M, Sun L, Xu F, Peng X, Zhang Y, Deng Y, Wu S. The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer. Front Cell Dev Biol 2021;9:694652. [PMID: 34195204 DOI: 10.3389/fcell.2021.694652] [Reference Citation Analysis]
8 Ma C, Luo H, Cao J, Zheng X, Zhang J, Zhang Y, Fu Z. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma. Front Mol Biosci 2020;7:571641. [PMID: 33102522 DOI: 10.3389/fmolb.2020.571641] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chen J, Yu K, Zhong G, Shen W. Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma. Cancer Cell Int 2020;20:157. [PMID: 32419773 DOI: 10.1186/s12935-020-01238-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
10 Jiang H, Zhao L, Chen Y, Sun L. A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. J Clin Lab Anal 2020;34:e23377. [PMID: 32474975 DOI: 10.1002/jcla.23377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kong W, Wang X, Zuo X, Mao Z, Cheng Y, Chen W. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma. Front Genet 2020;11:1037. [PMID: 33101369 DOI: 10.3389/fgene.2020.01037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Beeraka NM, Gu H, Xue N, Liu Y, Yu H, Liu J, Chen K, Nikolenko VN, Fan R. Testing lncRNAs signature as clinical stage–related prognostic markers in gastric cancer progression using TCGA database. Exp Biol Med (Maywood). [DOI: 10.1177/15353702211067173] [Reference Citation Analysis]
13 Jiang Z, Cheng P, Luo B, Huang J. Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer. Onco Targets Ther 2020;13:4271-82. [PMID: 32547061 DOI: 10.2147/OTT.S240973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Olmedo-suárez MÁ, Ramírez-díaz I, Pérez-gonzález A, Molina-herrera A, Coral-garcía MÁ, Lobato S, Sarvari P, Barreto G, Rubio K. Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs. Biomolecules 2022;12:513. [DOI: 10.3390/biom12040513] [Reference Citation Analysis]
15 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457. [PMID: 32973402 DOI: 10.1186/s12935-020-01550-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]